Agents in development for type 2 diabetes.

被引：1

作者：

Jarvis B. ^{[1
]}

Elkinson S. ^{[1
]}

机构：

[1] Adis International, Auckland

来源：

Drugs in R & D | 1999年 / 2卷 / 2期

关键词：

Adis International Limited; Ornithine; Acarbose; Insulin Glargine; Troglitazone;

D O I：

10.2165/00126839-199902020-00002

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：95 / 99

页数：4

共 4 条

[1]

Day C(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-53

[2]

Plosker GL(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus N Engl J Med 329 977-86

[3]

Faulds D(1999)Thiazolidinediones: a new class of antidiabetic drugs Diabet Med 16 179-92

[4]

Owens DR(1999)Troglitazone: a review of its use in the management of type 2 diabetes mellitus Drugs 57 409-38

← 1 →